Organic anion-transporting polypeptides: a novel approach for cancer therapy

Tianyu Liu1, Qingyong Li

  • 1State Engineering Laboratory of Bio-Resources Eco-Utilization, Northeast Forestry University, Ministry of Education , Harbin , China and.

Insights

Organic anion-transporting polypeptides (OATPs) are crucial transporters for drugs and nutrients. Their expression in tumors highlights their potential as anti-cancer drug targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Organic anion-transporting polypeptides (OATPs), encoded by SLCO genes, form a vital transporter superfamily.
  • They facilitate transmembrane transport of diverse drugs and endogenous compounds, including bile acids, hormones, and prostaglandins.
  • Eleven human OATPs exhibit distinct transport functions and tissue-specific expression patterns.

Purpose of the Study:

  • To review the role of OATPs in drug transport and their significance in cancer.
  • To highlight OATPs as potential biomarkers and therapeutic targets in oncology.

Main Methods:

  • Literature review of studies on OATP function, substrate specificity, and genetic polymorphisms.
  • Analysis of OATP expression in normal tissues and malignancies.
  • Evaluation of OATP involvement in the pharmacokinetics of clinical drugs.

Main Results:

  • OATPs transport numerous clinically relevant drugs, with OATP1B1, OATP1B3, OATP2B1, and OATP1A2 being key transporters.
  • Liver-specific OATP1B1 and OATP1B3, along with testis-specific OATP6A1, are upregulated in various cancers, serving as potential biomarkers.
  • Genetic variations in OATP genes influence substrate uptake and pharmacokinetics.

Conclusions:

  • OATPs are integral to drug and nutrient transport, with specific isoforms implicated in cancer progression.
  • Their expression in tumors and role in transporting anti-cancer drugs position OATPs as significant therapeutic targets for novel anti-cancer drug development.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...